Cover Image

Trastuzumab emtansine in locally advanced or metastatic HER2 positive breast cancer; GENESIS-SEFH drug evaluation report

Fuente: Redalyc

Saved in:

Bibliographic Details
Main Author:	Patricia Miranda Romero
Format:	Artículo científico
Language:	en
Published:	Sociedad Española de Farmacia Hospitalaria 2015
Subjects:	Medicina Lapatinib Breast Cancer Cost effectiveness Trastuzumab emtansine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study
by: Eyyup Cavdar
Published: (2022)

Lapatinib en combinación con trastuzumab en el tratamiento del cáncer de mama metastásico HER2 positivo: Experiencia de uso
by: C García-Muñoz
Published: (2014)

Real world study of pertuzumab-trastuzumab-chemotherapy versus trastuzumab-chemotherapy in neoadjuvant treatment of breast cancer
by: Rocío Díaz-Acedo
Published: (2020)

Cardiotoxicity associated with trastuzumab in normal clinical practice
by: C. Vicente
Published: (2009)

Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer
by: Iris Otoya, et al.
Published: (2024)

Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
by: Juan Carlos del Río-Valencia
Published: (2018)

Management of Trastuzumab Deruxtecan-Induced Heart Failure and Pneumonitis in a Patient with HER2-Positive Metastatic Breast Cancer
by: Seyyar, Mustafa, et al.
Published: (2025)

Real‐World Safety and Efficacy of Biosimilar Trastuzumab Emtansine (T‐DM1) in HER2‐Positive Breast Cancer: A Prospective Single‐Institution Study From India
by: Divya Gandrala, et al.
Published: (2026)

Estudio de adecuación a la ficha técnica de las prescripciones de trastuzumab en un hospital de tercer nivel
by: J.E. Vargas-Rivas
Published: (2012)

Trastuzumab deruxtecan versus trastuzumab emtansine in Asian patients with HER2‐positive metastatic breast cancer
by: Hiroji Iwata, et al.
Published: (2024)

Insights Into the Emerging Entity of HER2‐Low Breast Cancer
by: Georges El Haddad, et al.
Published: (2024)

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation reporta
by: María Espinosa Bosch
Published: (2016)

Clinical Outcomes of HER2‐Low Versus HER2‐Zero in HR‐Positive Metastatic Breast Cancer Treated With Endocrine Therapy With or Without CDK4/6 Inhibitors: A Multicenter Retrospective Study
by: Thiti Susiriwatananont, et al.
Published: (2025)

Alertas de cardiotoxicidad en el tratamiento con trastuzumab en cáncer de mama, 4 años de seguimiento
by: DANIEL A SANTOS
Published: (2019)

Evaluación ecocardiográfica de la función ventricular derecha para la detección temprana de la cardiotoxicidad inducida por antraciclinas
by: Jenny Karina Villasmil Camacho
Published: (2017)

Impact of Adjuvant Chemotherapy on Survival Outcomes in Intermediate‐ and High‐Risk ER+/HER2− Breast Cancer Stratified by Genomic Profiling: A Meta‐Analysis
by: Max Seabrook, et al.
Published: (2026)

Factors Influencing Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer: A Single‐Center Retrospective Study Focusing on ER and HER‐2 Status
by: Yadong Zhang, et al.
Published: (2026)

A comparative study of decision tree and support vector machine for breast cancer prediction
by: Matthew Idakwo Ogbe, et al.
Published: (2024)

Neuroendocrine breast carcinoma
by: Laura Pratas Guerra
Published: (2024)

Cardiotoxicidad por trastuzumab en pacientes con cáncer de mama. Serie de casos
by: Andreina Gómez
Published: (2019)

Long-term stability of trastuzumab in plasma and whole blood samples stored under different conditions
by: Jonathan González-García
Published: (2019)

Breast cancer patient's knowledge about radiotherapy and physical side effects in Awat radiation oncology center
by: Azzadin Kamal, Mahmood, et al.
Published: (2025)

Association of Chewing Tobacco and the Risk of Breast Cancer in Indian Women: A Multicentre Case‐Control Study
by: Romi Moirangthem, et al.
Published: (2026)

Enhancing Skin Cancer Diagnosis Through Fine‐Tuning of Pretrained Models: A Two‐Phase Transfer Learning Approach
by: Entesar Hamed I. Eliwa
Published: (2025)

Patterns of Postmastectomy Radiotherapy in Immediate Breast Reconstruction—Results From the iBRA‐2 Cohort Study
by: Tim Rattay, et al.
Published: (2026)

Improvement of Dosimetry Planning in 3D Conformal Radiotherapy for Breast Cancer With Lymph Nodes Using the High‐Tangential Tilted‐Supraclavicular Technique
by: Mazen Moussallem
Published: (2026)

Guardians of Sensation: Evaluating Metformin’s Power Against Chemotherapy‐Induced Neuropathy
by: Hamid Nasrolahi, et al.
Published: (2025)

Development of a Culturally Appropriate Text Messaging Platform for Improving Breast Cancer Screening Uptake Among Ghanaian Women in Metropolitan Areas
by: Ransford Paul Selasi Sefenu, et al.
Published: (2024)

Vacuum‐Assisted Excision and Assessing Residual Tumor Burden in Patients With Breast Cancer Following Neoadjuvant Chemotherapy (A Pilot Study)
by: Hawzhin Hashemi, et al.
Published: (2026)

Exploring Anti-Breast Cancer Effects of Live Pediococcus acidilactici and Its Cell-Free Supernatant Isolated from Human Breast Milk
by: Naa N. Adumuah, et al.
Published: (2024)

Potential Therapeutic Targets in Triple‐Negative Breast Cancer Based on Gene Regulatory Network Analysis: A Comprehensive Systems Biology Approach
by: Maryam Ahmadi, et al.
Published: (2024)

The Impact of Breast Density Notification on Anxiety in South Australian Women Undergoing Breast Cancer Screening
by: Avisak Bhattacharjee, et al.
Published: (2025)

Psychometric Validation of the Bangla Version of the Breast Cancer Fear Scale Among Female University Students in Bangladesh
by: Md. Ashfikur Rahman, et al.
Published: (2025)

Labels, Language, and Other Strategies to Improve Communication About Lower Grade Forms of Ductal Carcinoma In Situ of the Breast: A National Delphi Survey
by: Mavis S. Lyons, et al.
Published: (2025)

Long‐Term Management of Breast Cancer Bone Metastases: Two Case Reports
by: Xiaoting Lin, et al.
Published: (2025)

Reactive Axillary Lymphadenopathy Among Different COVID‐19 Vaccines: A Retrospective Study in Breast Sonography
by: Pin-Chi Huang, et al.
Published: (2025)

HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer
by: Sm Faysal Bellah, et al.
Published: (2025)

Effectiveness of a Breast Cancer Educational Conference Targeting Healthcare Workers in Honduras
by: Saranya Prathibha, et al.
Published: (2024)

Awareness, Attitudes, and Barriers to Breast Cancer Screening Among Breast Screening Health Education Week Attendees at King Saud Medical City, Riyadh
by: Atheer Alturki, et al.
Published: (2025)

Recurrent Hormone Receptor–Positive Breast Cancer With Multiple Sites of Distant Metastasis: A Case Report and Review of the Literature
by: Lu Li, et al.
Published: (2025)